Success Item Removed From Cart

Basket Summary
Close

Your Cart is Empty

Subtotal
$0
Sales Tax
$0
Total
$0
Back to browsing

Overview

Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis.

Drug Operating Profit Model

 width=

Hengmu Drug Details

Tenofovir amibufenamide (Hengmu) is a purine derivative, acts as antiviral agent. It is formulated as tablets for oral route of administration. Hengmu is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, and chronic hepatitis B infection.

Report Coverage

GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, potential applicable patients, drug margins, company expenses, and pricing estimates. Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company.

Reasons to buy

  • Better understand the quantitative value of a specific drug
  • Create or support internal NPV models to improve accuracy
  • Understand the profit a drug is expected to make, taking into account revenue and cost forecasts leveraging public and proprietary data sets.

What our clients have to say

More Reports

View More Reports